North America's leading commercial stem cells & regenerative medicine event


Where stem cell, regenerative medicine, cell & gene therapy biotechs gather, discussing strategies to develop & commercialize the next gen cure for unmet needs

 

SPONSOR NOW   REGISTER NOW

 

 

Bringing together two complementary events to discuss everything biotechs and cord blood banks need to know about commercial success

 

Position yourself as an industry leader

Contact us today to secure your position as a partner, sponsor or exhibitor at the show.

It's more than great content

This event is an opportunity to showcase your services to your target market. By sponsoring our event, you can  develop relationships, make sales and raise your company's profile.

Lead Generation Programme

Sponsoring involves more than just a two day event. We have access to the Total BioPharma community of almost 250,000 people. You provide us with great content, and we'll distribute it through email, our blog and multiple social media channels.

1-2-1 Partnering

Your success at the show is dependent on the quality relationships you build. Take a look at the delegate list before the event, decide who you want to meet and we'll make it happen.

 

SPONSORSHIP PROSPECTUS

 

Addressing unmet needs if only…


Despite its turns and tumbles, the stem cell and regenerative medicine sector thrives. Cancer, Alzheimer’s, rare diseases and a host of other diseases remain unsolved and the key could be in cell therapies. But challenges in ethics, clinical trial size, living raw materials, regulators’ not knowing how to assess this nascent space, hamper stem cell therapies’ way to market.

Are you ready? Top biopharma gather to tackle common barriers to commercial success in the the US stem cells & regenerative medicine market such as high development costs, time-consuming R&D and lengthy clinical trials.  

 

Stem Cells & Regenerative Medicine Congress 2015

Stem Cells & Regenerative Medicine Congress 2015

Stem Cells & Regenerative Medicine Congress 2015

Stem Cells & Regenerative Medicine Congress 2015

Stem Cells & Regenerative Medicine Congress 2015

Our Sponsors


  • Gold Sponsor

    Octane Medical Group at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    WuXi AppTec, Inc at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    Rainbow Scientific at Stem Cells & Regenerative Medicine Congress USA
  • Exhibitor

    Saint Gobain Life Sciences at Stem Cells & Regenerative Medicine Congress USA

SEE OUR SPONSORS

 

 

 

Take the chance out of networking

Quickly exchange business cards with attendees at our Speed Networking session

As a sponsor, take advantage of our 1-2-1 partnering service- let us arrange meetings for you

Crowdsource solutions with your peers at industry-led Roundtable sessions

Download the networking app before the event and make the most of your time by setting up meetings before you arrive

Unwind and network more informally with your peers at the Futuristic Networking Party

 

 

New Benefit- Risk, PSUR, Benefit-Risk Assessment, drug safety

New Benefit-Risk PSUR: Impact on Benefit-Risk Assessment

At the 2014 World Drug Safety Congress Americas, Anne Wolka, Eli Lilly and Company, gave a presentation on “New Benefit-Risk PSUR: Impact on Benefit-Risk Assessment”. Download and learn: The rebirth of the PSUR Objective of the PBRER Critical Analysis of Benefits Critical Analysis of Risks Integrated Benefit-Risk Analysis Impact of the PBRER So What Is a […]
top-50-pharmaceutical-companies-20130

Top 50 Pharmaceutical Companies 2014

The Pharmaceutical and Biotechnology continue to dominate the world’s R&D expenditure, with more companies in the top 10 than any other sector. This year, whilst Novartis has knocked Roche from their top spot, individual R&D spends by pharma and biotechs fail to compete with the likes of Volkswagen and Samsung who’s spends were around $11 […]

Asian biotechs to look beyond Asia for growth

Earlier this year at BioPharma Asia Convention, when we spoke to some speakers about their thoughts on the key growth strategy that Asian biotech companies should adopt, there seemed to be a unanimous agreement that looking beyond Asia is the way to go. “Biotech companies in Asia have to think globally, and link globally. “ […]

Join the Community

Innovation and strategy for pharmaceutical, biotech and R&D

Sign Up to Our Newsletter